Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Addex Therapeutics (ADXN) Current Leases (2018 - 2025)

Addex Therapeutics' Current Leases history spans 8 years, with the latest figure at $9609.0 for Q4 2025.

  • On a quarterly basis, Current Leases rose 15.22% to $9609.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $9609.0, a 15.22% increase, with the full-year FY2025 number at $9263.1, up 11.07% from a year prior.
  • Current Leases came in at $9609.0 for Q4 2025, up from $9482.1 in the prior quarter.
  • The five-year high for Current Leases was $334796.3 in Q1 2021, with the low at $8228.4 in Q1 2025.
  • Historically, Current Leases has averaged $174764.7 across 5 years, with a median of $237280.6 in 2023.
  • Biggest five-year swings in Current Leases: surged 35.53% in 2021 and later crashed 97.3% in 2024.
  • Year by year, Current Leases stood at $312009.1 in 2021, then decreased by 4.82% to $296985.3 in 2022, then grew by 3.99% to $308845.5 in 2023, then crashed by 97.3% to $8340.0 in 2024, then grew by 15.22% to $9609.0 in 2025.
  • Business Quant data shows Current Leases for ADXN at $9609.0 in Q4 2025, $9482.1 in Q3 2025, and $9048.3 in Q2 2025.